Assessment of Patient Satisfaction in Palliative Cancer When They Return Home After Hospitalization in Palliative Care

NCT02207543 | Terminated DMC

• 1 other identifier: PALSATIS
• Study Type: interventional
• Target: 4
• Locations: 1 country
• Sites: 1

Brief Summary

The proposed work is part of a multidisciplinary approach to continuity of care in the particular context of the palliative phase of cancer. In conducting this study, we would like to characterize, at the regional level, satisfaction with the care of patients and their families in their care home situations palliative cancer. This evaluation will be based on questionnaires adapted versions in French language satisfaction questionnaires recently validated for patients in palliative situation and supported home care. It will also identify the challenges faced by both patients, caregivers attending physicians. The evaluation of these elements is a prerequisite to propose ways of improving at a hospital palliative care for output relay and anticipate the coordination of care for optimal care of the patient at home, to meet the expectations of different stakeholders, or even prevent certain readmissions "avoidable".

Conditions

Cancer; Palliative Care; Home

Keywords

Cancer; Palliative care; home

Outcome Measures

Primary Outcomes (1)

• Patient care satisfaction

  Evaluation of satisfaction with the care of patients in palliative phase of cancer 15 days after their home return after hospitalization in palliative care.

  15 days after their home return

Secondary Outcomes (1)

• Satisfaction of the primary caregiver

  Satisfaction of the primary caregiver will be evaluated at day 15, months 1 to 6

Other Outcomes (2)

• Patient quality of life

  Patient quality of life will be evaluated at day 15, months 1 to 6

• The type and intensity of symptoms

  The type and intensity of symptoms will be evaluated on day 15, months1 to 6

Study Arms (1)

Medical telephonecontact

EXPERIMENTAL

Evaluations will be conducted by telephone 15 days after hospital discharge, 30 days and then every month until 6 months.

Other: Medical telephone contact

Interventions

Medical telephone contact OTHER

Evaluations will be conducted by telephone 15 days after hospital discharge, 30 days and then every month until 6 months.

Medical telephonecontact

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient (s) age (s) of 18 or more;
• Patient (s) reached (s) from cancer wholly palliative phase (estimated life expectancy of less than 3 months) in the judgment of the investigator;
• Patient (s) hospital (s) in palliative care and candidate for a return home;
• Patient (s) able to communicate with the investigator or his representative;
• Patient (s) have received clear information on the diagnosis and prognosis of their disease;
• Free and informed consent signed.

You may not qualify if:

• Patient (s) under guardianship or unable to give informed consent;
• Patient (s) whose cognitive functions can not be questioned.
• Patient (s) whose psychological distress does not participate in the study

Sponsors & Collaborators

• Centre Francois Baclesse: lead

Study Sites (1)

Centre François Baclesse

Caen, 14076, France

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

• Marie-Christine GRACH, MD

  Centre François Baclesse

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 1, 2014
• First Posted: August 4, 2014
• Study Start: June 1, 2014
• Primary Completion: March 1, 2016
• Study Completion: March 1, 2016
• Last Updated: February 10, 2017

Record last verified: 2016-03

Locations

FR (1)